Use of the steroid backbone in the search for a range of compounds as potential inhibitors of the enzyme 17β-hydroxysteroid dehydrogenase (17β-HSD)

被引：0
作者：
Soltani-Khankahdani, S. [1 ]
Dhanani, S. [2 ]
Owen, C. P. [1 ]
Ahmed, S. [1 ]
机构：
[1] Kingston Univ, Dept Pharm, Sch Chem & Pharmaceut Sci, Kingston, Surrey, England
[2] Kingston Univ, Sch Life Sci, Kingston, Surrey, England
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 2005年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [41] Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a series of 4-hydroxyphenyl ketones as potential inhibitors of 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3)
    Lota, Rupinder K.
    Dhanani, Sachin
    Owen, Caroline P.
    Ahmed, Sabbir
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4519 - 4522
  • [42] Oxidative activity of the type 2 isozyme of 17β-hydroxysteroid dehydrogenase (17β-HSD) predominates in human sebaceous glands
    Thiboutot, D
    Martin, P
    Volikos, L
    Gilliland, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (03) : 390 - 395
  • [43] Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-hydroxyphenyl ketones as potent and specific inhibitors of the type 3 of 17β-hydroxysteroid dehydrogenase (17β-HSD3)
    Lota, Rupinder K.
    Olusanjo, Moniola S.
    Dhanani, Sachin
    Owen, Caroline P.
    Ahmed, Sabbir
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2008, 111 (1-2) : 128 - 137
  • [44] CHARACTERIZATION AND INTRAMITOCHONDRIAL DISTRIBUTION OF A 17-BETA-HYDROXYSTEROID DEHYDROGENASE (17-BETA-HSD) OF HUMAN ENDOMETRIUM
    POLLOW, K
    LUBBERT, H
    ACTA ENDOCRINOLOGICA, 1975, 80 : 216 - 216
  • [45] Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities
    Le Bail, JC
    Pouget, C
    Fagnere, C
    Basly, JP
    Chulia, AJ
    Habrioux, G
    LIFE SCIENCES, 2001, 68 (07) : 751 - 761
  • [46] 17 beta-hydroxysteroid dehydrogenase: Inhibitors and inhibitor design
    Penning, TM
    ENDOCRINE-RELATED CANCER, 1996, 3 (01) : 41 - 56
  • [47] Novel and potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors
    Lawrence, HR
    Vicker, N
    Allan, GM
    Smith, A
    Mahon, MF
    Tutill, HJ
    Purohit, A
    Reed, MJ
    Potter, BVL
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) : 2759 - 2762
  • [48] The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors
    Vicker, Nigel
    Sharland, Christopher M.
    Heaton, Wesley B.
    Gonzalez, Ana M. Ramos
    Bailey, Helen V.
    Smith, Andrew
    Springall, Jeremy S.
    Day, Joanna M.
    Tutill, Helena J.
    Reed, Michael J.
    Purohit, Atul
    Potter, Barry V. L.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 259 - 265
  • [49] Bicyclic Substituted Hydroxyphenylmethanones as Novel Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) for the Treatment of Estrogen-Dependent Diseases
    Oster, Alexander
    Hinsberger, Stefan
    Werth, Ruth
    Marchais-Oberwinkler, Sandrine
    Frotscher, Martin
    Hartmann, Rolf W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 8176 - 8186
  • [50] STEROID SPECIFICITY OF 17 BETA-HYDROXYSTEROID DEHYDROGENASE OF HUMAN PLACENTA
    ADAMS, JA
    JARABAK, J
    TALALAY, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1962, 237 (10) : 3069 - &
12345